(Q39333424)

11 September 2017

title

Unsuspected allies: chemotherapy teams up with immunity to fight cancer (English)

1 reference

11 September 2017

author

Jo A Van Ginderachter

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122755%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Damya Laoui

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122755%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Eva Van Overmeire

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122755%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

1 October 2013

1 reference

European Journal of Immunology

11 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122755%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122755%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122755%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

2538-2542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122755%20AND%20SRC:MED&resulttype=core&format=json

Hallmarks of Cancer: The Next Generation

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

The secret ally: immunostimulation by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Stat1 is a suppressor of ErbB2/Neu-mediated cellular transformation and mouse mammary gland tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

In vivo inhibition of c-MYC in myeloid cells impairs tumor-associated macrophage maturation and pro-tumoral activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042

inferred from DOI database lookup

7 January 2021

based on heuristic

Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344042